Mitosis, Cytoskeleton Regulation, and Drug Resistance in Receptor Triple Negative Breast Cancer

Alexandre Matov

2024-08-17

Abstract:During cell division, the receptor triple-negative MDA-MB-231 mitotic spindles are the largest in comparison to other BC cell lines. Many of the MDA-MB-231 spindles exhibit rapid lateral twisting during metaphase, which remains unaffected by knockdown of the oncogene Myc and treatment with inhibitors of the serine/threonine-protein kinase B-Raf and the epidermal growth factor receptor (EGFR), alone or in any combination. The MDA-MB-231 cells are the most aggressive and rapidly form metastatic tumors in xenograft transplant models, and exhibited very high proliferation rates when plated as three-dimensional cultures in Matrigel. Quantitative image analysis of microtubules (MTs) in six BC cell lines - MDA-MB-231 (receptor negative), HCC-1143 (receptor negative), HCC-3153 (receptor negative), ZR75B (estrogen receptor-positive), LY2 (progesterone receptor-positive), HCC-1428 (estrogen receptor-positive, progesterone receptor-positive) - demonstrated that the rotational spindle rocking of MDA-MB-231 cells during metaphase appears coupled with a significant increase in MT polymerization rates during interphase, which likely shortens interphase and accelerates cell cycle progression and mitotic entry. Unlike the uniform treadmilling rates of about 21 um/min in kinetochore MTs during metaphase we measured across cell lines, MDA-MB-231 cells in interphase exhibit the fastest MT polymerization dynamics of about 19 um/min and this is coupled with abnormal mitotic spindle oscillations of almost 30 um/min. This aberrant behavior in MDA-MB-231 spindles may represent a therapeutically targetable disrupted mechanism of spindle positioning in receptor triple-negative breast cancer (TNBC) cells leading to tumor aggressiveness. In this manuscript, we outline a strategy for the selection of the most optimal tubulin inhibitor based on the ability to affect MT dynamics.

Quantitative Methods

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is the drug - resistance mechanism caused by abnormal microtubule dynamics during the cell division process of receptor triple - negative breast cancer (TNBC). Specifically, by analyzing the microtubule dynamic characteristics in different breast cancer cell lines, the researchers aim to:

1. **Clarify the relationship between microtubule organization and drug sensitivity**: The researchers developed software tools to observe the changes of microtubules and key cellular proteins in living cells in real - time, especially after drug treatment, in order to understand how microtubule organization affects the sensitivity of cells to microtubule inhibitors.

2. **Explore the unique microtubule dynamic characteristics in TNBC cells**: The study found that, compared with receptor - positive breast cancer cells, TNBC cells exhibit a faster microtubule polymerization rate during interphase, which may lead to an accelerated cell cycle and faster entry into division, thereby increasing their proliferation rate. In addition, TNBC cells exhibit significant spindle oscillation movements during metaphase of mitosis, and this abnormal behavior may represent a potential therapeutic target.

3. **Provide a theoretical basis for personalized medical strategies**: By analyzing in detail the responses of different breast cancer cell lines to six microtubule inhibitors, the researchers hope to provide data support for selecting the most effective microtubule inhibitors, especially for TNBC patients. Since this type of cancer is generally resistant to traditional chemotherapy, it is particularly important to find new treatment strategies.

4. **Develop a drug - sensitivity detection method based on microtubule dynamics**: The ultimate goal is to establish a system that can use patient - derived normal tissue cells and tumor cells for in - vitro detection, evaluate the cytoskeletal reorganization caused by the disease, and thus select drugs that can reverse these changes to achieve the maximum therapeutic effect.

Through the above research, the paper not only deepens the understanding of TNBC cell microtubule dynamics and its relationship with drug resistance, but also provides important scientific basis for the development of more effective personalized treatment regimens.